What did Surgicore 5th Avenue pay for North Queens Surgical Center?

Surgicore 5th Avenue acquired North Queens Surgical Center for $9.9M in 2019 (21.8x EBITDA), equivalent to 1.20x revenue. Target revenue was approximately $8.3M. Target EBITDA was approximately $0.5M.

What does North Queens Surgical Center do?

North Queens Surgical Center is a ambulatory surgery center business.

What multiple did Surgicore 5th Avenue pay for North Queens Surgical Center?

21.8x EBITDA and 1.20x revenue, based on disclosed deal value of $9.9M and disclosed financials.

M&A TRANSACTION · 2019

North Queens Surgical Center acquired by Surgicore 5th Avenue

$9.9M· 21.8x EBITDA· 1.20x revenue

Target

North Queens Surgical Center

Acquirer

Surgicore 5th Avenue

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$8.3M

EBITDA

$0.5M

Deal Value

$9.9M

EV/EBITDA

21.8x

Context

This $9.9M acquisition of North Queens Surgical Center by Surgicore 5th Avenue sits in the ambulatory surgery center sub-vertical. The 21.8x EBITDA multiple paid in 2019 can be compared against the population median for ambulatory surgery center transactions of similar size on our Ambulatory Surgery Center valuation hub. Surgicore 5th Avenue is acquiring as a strategic buyer; see how strategic acquirers typically price ambulatory surgery center businesses on our Ambulatory Surgery Center strategic buyer-pool page.

Source

Data sourced from CON filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own ambulatory surgery center

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the North Queens Surgical Center acquisition.

Citation: ExitValue.ai. (2019). North Queens Surgical Center acquired by Surgicore 5th Avenue. https://exitvalue.ai/deals/north-queens-surgical-center-acquired-by-surgicore-5th-avenue-hc-2019-0151